Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 5.0 | 5.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 1.66 | 1.42 |
NAV | ₹992.07 | ₹108.49 |
Fund Started | 04 Jun 1998 | 08 Apr 2008 |
Fund Size | ₹21656.65 Cr | ₹69762.55 Cr |
Exit Load | Exit load of 1% if redeemed within 1 month. | Exit load of 1% if redeemed upto 1 year. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 8.98% | 6.77% |
3 Year | 25.46% | 21.54% |
5 Year | 29.35% | 23.96% |
1 Year
3 Year
5 Year
Equity | 94.73% | 92.69% |
Cash | 4.56% | 6.45% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
Maruti Suzuki India Ltd. | 4.91% |
Larsen & Toubro Ltd. | 4.11% |
FSN E-Commerce Ventures Ltd. | 3.97% |
ICICI Bank Ltd. | 3.49% |
SBI Cards And Payment Services Ltd. | 3.47% |
Axis Bank Ltd. | 3.14% |
Alkem Laboratories Ltd. | 2.77% |
Motherson Sumi Wiring India Ltd. | 2.64% |
Avenue Supermarts Ltd. | 2.59% |
Reliance Industries Ltd. | 2.56% |
Name | Assets |
---|---|
HDFC Bank Ltd. | 9.66% |
ICICI Bank Ltd. | 8.99% |
Reliance Industries Ltd. | 6.40% |
Larsen & Toubro Ltd. | 6.26% |
Bharti Airtel Ltd. | 4.45% |
Axis Bank Ltd. | 4.31% |
Maruti Suzuki India Ltd. | 4.16% |
Ultratech Cement Ltd. | 3.81% |
Infosys Ltd. | 3.46% |
Sun Pharmaceutical Industries Ltd. | 2.72% |
Name | Ihab Dalwai | Vaibhav Dusad |
Start Date | 29 Jan 2018 | 02 May 2020 |
Name
Start Date
Description | The scheme seeks to generate long-term capital appreciation from a portfolio that is invested predominantly in equity and equity related securities of large-cap and mid-cap companies. | The scheme seeks to generate long term capital appreciation and income distribution to investors from a portfolio that is predominantly invested in equity and equity related securities of large cap companies. |
Launch Date | 04 Jun 1998 | 08 Apr 2008 |
Description
Launch Date